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Abstract Health care of severe burn patients is highly spe-
cialized and may require international patient transfer. Burn
patients have an increased risk of developing infections.
Patients that have been hospitalized in countries where
carbapenemase-producing microorganisms (CPMO) are en-
demic may develop infections that are difficult to treat. In
addition, there is a risk on outbreaks with CPMOs in burn
centers. This study underlines that burn patients may exten-
sively be colonized with CPMOs, and it provides best practice
recommendations regarding clinical microbiology and infec-
tion control. We evaluated CPMO-carriage and wound colo-
nization in a burn patient initially treated in Romania, and
transported to the Netherlands. The sequence types and ac-
quired beta-lactamase genes of highly-resistant microorgan-
isms were derived from next generation sequencing data.
Next, we searched literature for reports on CPMOs in burn
patients. Five different carbapenemase-producing isolates
were cultured: two unrelated OXA-48-producing Klebsiella
pneumoniae isolates, OXA-23-producing Acinetobacter
baumanii, OXA-48-producing Enterobacter cloacae, and
NDM-1-producing Providencia stuartii. Also, multi-drug re-
sistant Pseudomonas aeruginosa isolates were detected.
Among the sampling sites, there was high variety in
CPMOs. We found 46 reports on CPMOs in burn patients.
We listed the epidemiology of CPMOs by country of initial
treatment, and summarized recommendations for care of these
patients based on these reports and our study.
Keywords Carbapenemase . CPE . Burn patients . Infection
control . Review .Molecular epidemiology
Introduction
In October 2015, the crowded nightclub Colectiv in
Bucharest, Romania caught on fire due to indoor use of pyro-
technics. In total, 64 visitors died from burn wounds and/or
inhalation of smoke, and 144 were injured. The injured visi-
tors were immediately transported to 12 nearby hospitals in
Bucharest and Ilfov County for medical care [1]. Since appro-
priate medical care could not be provided for all patients,
international aid was requested. About 80 patients were
transported to various countries, including 16 to
The Netherlands and Belgium, after they had been hospital-
ized for over a week in Romania.
Romania is a country with a high prevalence of
carbapenemase-producing microorganisms (CPMO) [2, 3].
As burn patients have a high risk of developing infectious
complications, this is a serious problem to be reckoned with.
Wound infection with CPMO complicates the treatment of
patients with burns [4, 5]. Patients suffering from these kind
of infections have to be treated with last-line antibiotic
schemes. These schemes are most often sub-optimal for treat-
ment of the infection and have more adverse effects. In addi-
tion to the impact of CPMO-infection on the treatment of the
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individual patient, the introduction of CPMOs in the hospital
also may lead to nosocomial transmission of CPMO resulting
in hospital outbreaks.
Burnwounds are highly prone to long-term colonization by
nosocomial bacteria. It has been reported that in more than
90% of patients the wounds were colonized by the seventh
day, and that constitution of colonizing microorganisms in
individual burn wounds changes over time [6, 7]. Wound col-
onization can subsequently result in severe invasive infection,
a leading cause of mortality in patients with burn injury [8].
Restrictive and targeted use of antibiotics is important in
treatment of burn patients, in particular in those with CPMOs.
Guidelines from the European Burns Association recommend
the use of Btopical creams with good antimicrobial effects
without the risk for resistance or allergy .^ BThe use of prophy-
lactic systemic antibiotics is not supported by evidence^ [9,
10]. Infections are most often caused by the microorganisms
that colonize the burn wounds [11, 12]. Thus, it is important to
culture wounds on admission, also before signs of infection, to
know which antibiotics to start in case of infection.
Here, we describe the diversity in CPMO cultured at ad-
mission from several burn wounds and body sites in a burn
patient from the Colectiv fire disaster transported to a dedicat-
ed Burn Centre in the Netherlands. Next, we performed an
analysis of literature focusing on CPMO in patients with
burns. By this, we show that the presented case of extensive
burn wound colonization with CPMO is not an exception.
Finally, we provide specific recommendations for medical
care of burn patients transported fromCPMO endemic regions
to other countries with low CPMO prevalence. For non-
endemic countries such as the Netherlands, international
transfer of patients carrying CPMOs imposes a risk on dis-
semination to other hospitalized patients.
Case description
A Romanian victim of the Colectiv fire disaster had been
admitted to BSpitalul Clinic de Urgenta^ in Bucharest on
October 31st 2015 with a total body surface area (TBSA) burn
of approximately 30%. The patient was in his 20s and had an
uncomplicated medical history before this incident.
There were IIA–IIB degree burn lesions on the face, pos-
terior cervical area, right scapular area, deltoid area bilaterally
and IIB–III degree burns on both hands, forearms, and scalp.
Meshed split skin grafting had been performed to cover the
burns on his right lower arm and hand. On the IC unit, the
patient had received broad-spectrum empirical antibiotic ther-
apy with Piperacillin/ Tazobactam 4.5 g tid and Linezolid
600 mg bid. Based on results of wound cultures that revealed
Acinetobacter spp., antibiotics were switched to Colistin 2
million units tid for the treatment of wound infection. For
topical treatment of the wounds, silversulfadiazine,
kanamycine ointments, and betadine scrub were used. No ad-
ditional information on the microbiological cultures was men-
tioned in the Romanian discharge notes.
The patient was transported by airplane and ambulance to
the Burn Centre of the Martini Hospital (BCMH) in
Groningen, The Netherlands on November 7th 2015, 7 days
after the incident. Upon admission to the BCMH, the patient’s
TBSA burned was still approximately 10%. Admission cul-
tures taken from the wounds and body sites (nose, throat,
perineum) showed extensive colonization with CPMOs (see
results section). Following regular Dutch infection control
recommendations, the patient was consequently placed in iso-
lation. However, in this phase there was no need for treatment
with systemic antibiotics. The burn wounds were topically
treated with silversulfadiazine ointment. After 12 days, defin-
itive covering of non-healing sites was opportune after en-
largement of autologous donor skin in a ratio of 1:1.5. Skin
defects on both hands and ears were covered with skin grafts
taken from the right upper leg. Good take of the grafts was
observed in the weeks after surgery. Pressure gloves were used
to augment the healing of the hands. Through extensive phys-
ical and occupational therapy, the patient regained his ability
to perform normal daily activities. The patient was discharged
from the hospital after 34 days.
After discharge, the patient’s air-locked room with sanitary
facility was disinfected. Subsequently taken environmental
samples were negative.
Methods
Culture and characterization of bacterial isolates
Upon admission, screening throat, nose, perineum, rectum,
and wound sample cultures were taken for detection of
MRSA and highly-resistant gram negative bacteria (HRGN).
Cultures from wounds were taken from the following loca-
tions: the anterior left elbow, the left and right ear, right shoul-
der and the left groin onNovember 9th; the left palm, and right
upper back side on November 16th; the dorsum of the left
hand, the right fingers and a repeated culture of right and left
ear on November 30th. In total, 29 cultures were taken during
the hospital stay: 14 screening cultures, three urine cultures,
and 12 wound cultures. Burn wounds were cultured using sets
of RODAC plates with five different media: blood agar +5%
sheepblood (BA + 5%SB), colistin oxolinic-acid blood agar,
mannitol salt agar, MacConkey agar no.3 + crystalviolet,
Sabouraud dextrose agar + aztreonam/vancomycin
(Mediaproducts, the Netherlands). For sampling, the plates
were applied directly on the wounds. The plates were incubat-
ed for 48 h at 35 °C. Screening for methicillin-resistant
Staphylococcus aureus (MRSA) was done with Xpert
MRSA Gen3 assay (Cepheid, France) and by culture using
Eur J Clin Microbiol Infect Dis
BA + 5%SB and CHROMagar ID MRSA (bioMérieux,
France) plates. Species determination of isolates was per-
formed by using Maldi-TOF MS (bioMérieux, France).
Antibiotic susceptibility was tested using VITEK 2 XL
(bioMérieux, France). Minimal inhibitory concentrations
(MICs) to tigecyclin, amikacin, and fosfomycin were tested
using Etests according to manufacturer’s guidelines on
Mueller Hinton agar (AB Biodisk, Germany). Susceptibility
was interpreted according to EUCAST guidelines [13]. Using
whole genome sequencing data, we characterized the CPMO
isolates and identified acquired resistance genes as described
before [14]. In short, genomic DNA was extracted and pre-
pared libraries were run on a MiSeq platform (Illumina, USA)
generating paired-end 250-bp reads. De novo assembly of
paired-end reads was performed using CLC Genomics
Workbench v7.5 (QIAGEN, Germany) after quality trimming
(Qs ≥ 20) with optimal word size. The acquired antimicrobial
resistance genes were identified by uploading assembled ge-
nomes to the Resfinder server v2.1 [15]. The MLST-types
were assessed using SeqSphere v3.4.0 (Ridom GmbH,
Germany).
Patient informed consent and approval of local ethical com-
mittee have been obtained. All of the assessed culture samples
were taken in routine diagnostics.
Literature analysis
We performed a literature search in PubMed to assess the
epidemiology of CPMOs in burn wound care and recommen-
dations for care of these patients by the following search strat-
egy: ((burn[MeSH] OR burn*[TIAB] OR burn*[All Fields]))
AND ((carbapenemase[MeSH] OR carbapenemase[All
Fields] OR carbapenem resistant[MeSH] OR carbapenem
resistant[All Fields] OR carbapenemase producing
organisms[MeSH] OR carbapenemase producing
organisms[All Fields] OR carbapenemase producing
Enterobacteriacae[MeSH] OR carbapenemase producing
Enterobacteriacae[All Fields] OR panresistant[MeSH] OR
panresistant[All Fields] OR carbapenemase producing
microorganisms[MeSH] OR carbapenemase producing
microorganisms[All Fields])). Studies up to December 2016
were retrieved and screened by their title and abstract for their
relevancy on the topic.
Results
Cultures
MRSA diagnostics were all negative; methicillin-susceptible
S. aureus was cultured from nose and the burn wounds. We
present an overview of characteristics of the isolated HRGNs
in Table 1. In total, six different HRGNs were detected: five
different carbapenemase-producing isolates, and one
carbapenem-resistant Pseudomonas aeruginosa isolate. The
carbapenemase-producing isolates included OXA-48-
producing Klebsiella pneumoniae isolates of ST type 147,
and 395, OXA-23-producingAcinetobacter baumanii ST type
231, OXA-48-producing Enterobacter cloacae ST type 114,
and NDM-1-producing Providencia stuartii.
An overview of all body locations and isolated HRGNs is
presented in Fig. 1. Screening cultures for carriage of HRGNs
were positive in nose (4 different isolates), perineum (3 differ-
ent isolates), rectum (1 isolate) and throat (1 isolate). Cultures
from the wound sites showed varying colonization with
HRGNs. All sampled wound sites were colonized by
HRGNs. The highest number of HRGNs 5/6 were isolated
from the groin wound, a donor site wound after the grafting
procedures done in Romania. The MDR Pseudomonas
aeruginosa isolates were exclusively detected in samples from
the upper body. We observed differences in colonization in
similar body regions: the right forearm was positive for single
isolates of highly-resistant Enterobacter cloacae ,
Pseudomonas aeruginosa, and Acinetobacter baumanii,
whereas the left forearm sample grew Klebsiella pneumoniae.
The matching culture results between urine and both hands are
remarkable: in all three samples the NDM-1-producing
Providentia stuartii were cultured.
All isolates tested resistant to cotrimoxazol, ciprofloxacin
and aminogycosides, except for Klebsiella pneumoniae iso-
lates of ST 395 and OXA-48-producing Enterobacter cloacae
which were susceptible to amikacin. Only the NDM-1 pro-
ducing Providencia stuartii NDM-1 and Klebsiella
pneumoniae ST type 147 were susceptible to fosfomycin.
Two colistin-resistant isolates were detected: an OXA-48-
producing Providencia stuartii, which is intrinsically resistant,
and an NDM-1-producing Klebsiella pneumoniae.
In addition, multiple carbapenem-non-susceptible
Pseudomonas aeruginosa isolates of MLST ST235 were
grown. The Pseudomonas isolates were multidrug resistant,
testing resistant to antipseudomonal beta-lactams,
fluorquinolones, and aminoglycosides, and susceptible to
colistin.
Review
In our review search we found 84 reports on CPMOs in burn
wound care. Of these, 38 were off-topic, thus we included 46
reports. To assess the epidemiology, we present a country by
country overview (Table 2) of reports on CPMOs in burn care
centers. The country of initial care is shown.
CPMOs in burn patients have been reported from institu-
tions over all continents.
The CPMOs included Acinetobacter baumanii,
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Klebsiella pneumoniae, Enterobacter cloacae, and
Providencia stuartii. In these CPMOs, carbapenemase sub-
types of KPC, NDM, VIM, IMP and OXAwere detected.
The highest number of reports originated from Iran. In 17
publications, patients with burns hospitalized in Iran with
carbapenem-resistant Acinetobacter baumanii and
Pseudomonas aeruginosa were reported. The great diversity
of carbapenemases detected in Acinetobacter baumanii in the
Iranian studies is remarkable. One isolate even produced
KPC, VIM and OXA-23, representing three different
carbapenemases [39].
With our search, we retrieved two studies that described
victims of the Colectiv fire disaster from Romania who were
treated in England. As in our study, each of them was colo-
nized and or infected with an extraordinary diversity of
CPMOs. NDM-producing Klebsiella pneumoniae, OXA-48-
producing Klebsiella pneumoniae and Escherichia coli,
OXA-40-producing Acinetobacter baumanii and
carbapenem-resistant Pseudomonas aeruginosa were isolated
from these patients [13, 14]. The prolonged duration of hos-
pitalization in Romania may have contributed to this extensive
colonization with CPMOs. No transfer information had been
given to their service about previous microbiology results.
One of their patients died of pan-resistant NDM-producing
Klebsiella pneumoniae septicemia within 48 h of admission.
A second case died from severe sepsis due to extensive infect-
ed burn injuries: a pan-resistant OXA-48-producing
Klebsiella pneumoniae grew in the blood culture. Our patient
fortunately did not develop infections requiring treatment with
systemic antibiotics. Nonetheless, we proactively tested anti-
biotic susceptibilities for last-line treatment options in all the
isolates.
Recommendations
The Netherlands is a non-endemic country for CPMOs. To
maintain this status, we put maximum effort in surveillance
and infection control to prevent unnoticed introduction and
dissemination of CPMOs. Experience with treatment of burn
patients from endemic countries in countries with low CPMO
prevalence has been described in six studies [18, 19, 26, 28,
56, 57]. In Table 3, we provide an overview of advice based on
these studies completed by recommendations from the present
study. All of the studies were alert for the serious risk of
CPMO-carriage in transferred patients after hospitalization
abroad. Outbreaks with CPMO or outbreak strains or evalua-
tion of contact precautions after an outbreak were described in
eight studies [19, 23, 26, 27, 51, 57, 62, 63]. To reduce the risk
of transmission of CPMO, patients should be treated in con-
tact isolation in single-patient rooms until culture results are
known. Not only can bacteria spread directly by hand con-
tacts [28, 64–66], but also indirectly through the environ-
ment and by medical equipment [28, 56, 64–66].
Therefore, we recommend standardized guidelines for the
transfer of severely-ill patients between European coun-
tries, where detailed procedures on communication,
screening and infection prevention measures are described.
Especially for specific treatment and in case of internation-
al help, clinical staff organizing treatment abroad need to
be aware of such guidelines. Furthermore, we recommend
education of staff in hand hygiene and isolation precau-
tions, enhancement of disinfection of patient rooms, and
single-use of medical equipment if feasible for treatment
of burn patients. When transmission of CPMOs is
suspected, isolates should be typed and their molecular
Fig. 1 Overview of all body locations and isolated HRGNs. CPE Carbapenemase producing Enterobacteriacae, CPAB Carbapenemase producing
Acinetobacter baumanii, MDR Multidrugresistant
Eur J Clin Microbiol Infect Dis
characteristics should be compared to confirm the clonal
spread. Based on this, an outbreak investigation should be
started. Control of CPMO or the roll-back of CPMO is
today one of the most important goals.
Table 2 Review of reported
carbapenem-resistant bacterial
species isolated from burn pa-
tients with the country of initial
care
Country Study Species Carbapenemase
Afghanistan [16] P. stuartii NDM-1
[16] P. aeruginosa VIM-1
Algeria [17, 18] P. aeruginosa NDM-1; VIM-4
[18, 19] A. baumanii OXA-23
Bulgaria [20] P. aeruginosa n.r.
[20] A. baumanii n.r.
Brazil [21] P. aeruginosa n.r.
China [22–24] P. aeruginosa IMP-4; VIM-2
[24, 25] A. baumanii OXA-23
[24] K. pneumoniae n.r.
Egypt [26] A. baumanii n.r.
France [27] A. baumanii OXA-58
India [28] K. pneumoniae OXA-48&NDM
[29, 30] P. aeruginosa n.r.
[30] A. baumanii n.r.
Iran [31–41] A. baumanii KPC&VIM&OXA-23; VIM&OXA-23;
KPC&OXA-23; OXA-23; OXA-40;
OXA-23&OXA-40; OXA-23&
OXA-58; OXA-23&OXA-40&OXA-58;
OXA-40&OXA-58; OXA-23&OXA-58;
OXA-143; OXA-58; OXA-23&OXA-24;
OXA-24; KPC; VIM
[41–47] P. aeruginosa IMP&VIM; IMP; VIM; KPC; AIM
[41, 48, 49] K. pneumoniae KPC
Israël [7] P. aeruginosa n.r.
[7] A. baumanii n.r.
[7, 50] K. pneumoniae KPC-3
Italy [51] A. baumanii n.r.
Libya [52] A. baumanii OXA-23 like; NDM-1
Morocco [19] A.baumanii n.r.
Mongolia [53] A. baumanii OXA-58
P. aeruginosa VIM-2
Pakistan [28, 54] K. pneumoniae OXA-48&NDM; OXA-48
[28] P. stuartii NDM
P. aeruginosa VIM
K. oxytoca NDM
E. coli OXA-48&NDM
A. baumanii OXA 23
Poland [55] A. baumanii OXA-23 like; OXA-40 like
Romaniaa This study, [28, 56] A. baumanii OXA-40; OXA-23
[28] E. coli OXA-48
[56] P. aeruginosa n.r.
This study, [56] K. pneumoniae OXA-48&NDM-1; OXA-48
This study P. stuartii NDM-1
This study E. cloacae OXA-48
Tunisia [57–59] P. aeruginosa VIM-2
[19] A.baumanii OXA-23 like
Turkey [60] P. aeruginosa n.r.
[60] A. baumanii n.r.
USA [61] E. cloacae KPC-3
[61, 62] K. pneumoniae KPC
[63] A. baumanii OXA-40
Carbapenemase types/subtypes are shown if tested
n.r. no carbapenemase genotyping reported
Some isolates produce multiple carbapenemases. Carbapenemase combinations are noted by B&^
a All Romanian studies are on victims of the Colectiv fire disaster
Eur J Clin Microbiol Infect Dis
Samples of throat, nose, rectum, perineum, and all wound
sites should be taken at admission to detect all CPMOs and
MRSAs carried by the patient. It is important to detect all
CPMOs and test their susceptibility patterns, so that targeted
therapy can be started in case of systemic infections. Ideally,
treating clinicians should already be informed upon patient
admission about culture results from the hospital of discharge.
For this purpose, good communication within health care net-
works is needed. This is may be facilitated by the European
Burns Association.
To summarize, we showed that burn patients that have been
hospitalized in a CPMO endemic country can be colonized by
an extensive variety of CPMOs. CPMO presence may differ
among body locations, thus we recommend culturing of mul-
tiple wound sites. Burn wound colonization by CPMOs is a
worldwide problem. There is a high risk for burn patients to
develop invasive infections by CPMOs, which require
targeted antibiotic therapy. In addition, there is the risk on
hospital outbreaks by these CPMOs. Therefore, medical care
facilities treating patients with burns transported from endem-
ic regions should have advanced medical microbiology, and
infection control systems in place to detect CPMOs, treat in-
fections, and prevent onward transmission.
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